Amiodarone-induced hepatitis can occur and cause failure to thrive, requiring high clinical suspicion and potentially liver biopsy for diagnosis in patients with pre-existing cirrhosis.
Amiodarone causing side effects on the liver is often discussed in the literature. Amiodarone-induced hepatitis occurs in less than 3% of patients on amiodarone and is easily overlooked. We present a rare case of amiodaroneinduced hepatotoxicity causing failure to thrive in an 81 year old man with a history of cryptogenic cirrhosis and further endeavor to discuss a literature review of amiodarone induced hepatotoxicity. Amiodarone-induced hepatitis should be kept in the differential diagnosis of chronic liver disease even in patients with a previous diagnosis of cirrhosis. If the clinical suspicion is high, a liver biopsy is required to make a diagnosis because liver function tests may not be helpful in someone who already has cirrhosis of the liver. Direct hepatotoxicity and idiosyncrasy contribute to liver injury. Chronic liver injury is hypothesized to cause failure to thrive.
No takes yet. Share an insight, caveat, or question.
Pendyala VS (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: